The present disclosure provides a topical composition comprising (a) 70 to 95% (w/w)
of a triglyceride; (b) 1 to 15% (w/w) of an ester of C8 to C16 fatty acid; and (c) 0.1 to
0.3% (w/w) of vitamin E, wherein the triglyceride is a medium chain triglyceride
comprising C6 to C12 fatty acids. ...